Advances in relationship between smoking and bladder cancer

Aiwei LI,Yan QIAO,Xi ZHU,Jie ZHANG
DOI: https://doi.org/10.3781/j.issn.1000-7431.2016.55.106
2016-01-01
Tumori
Abstract:Bladder cancer is a common malignancy of the urinary system. Its incidence varies considerably by gender and regions. Smoking is the most important risk factor of bladder cancer. It affects the pathogenesis of bladder cancer through genes, such as glutathione S-transferase M1 (GSTM1), N-acetyl transferase 2 (NAT2), prostate stem cell antigen (PSCA) and chromobox 6 (CBX6)/apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3A (APOBEC3A). Recently, telomerase reverse transcriptase (TERT), cytochrome P450 family 1 subfamily A member 2 (CYP1A2), solute carrier family 14 member 1 (SLC14A1) and radial spoke protein 3 homolog (RSPH3)/ T-cell activation RhoGTPase activating protein (TAGAP)/ezrin (EZR) are reported to increase the risk of bladder cancer and this modification is more noticeable for the smokers. These genes will be of help for studying how smoking affects bladder cancer and the prevention strategies of the disease. DOI:10.3781/j.issn.1000-7431.2016.55.106
What problem does this paper attempt to address?